Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Phase I trial studies vandetanib combination therapy for brain cancer

April 27, 2012

Studies assess GS-9620-induced INF-alpha response and antiviral effects

April 27, 2012

First-in-human data confirm safety of Repligen product for spinal muscular atrophy

April 26, 2012

Abbott research results in new potential analgesics

April 26, 2012

Troponin activator shows promise in patients with ALS

April 26, 2012

Novel data presented on launched antiepileptic at ongoing AAN meeting

April 26, 2012

Chinese study yields potential biomarker of PAH severity due to heart disease

April 26, 2012

New data disclosed on first PI3Kalpha-specific anticancer agent to enter clinic

April 26, 2012

New Presidio product shows promise to treat hepatitis

April 25, 2012

Phase I data encourage advancement of candidate MS drug to phase II

April 25, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...